Shares of Target Corporation (NYSE: TGT) dropped 1% on Thursday. The stock has gained over 9% in the past three months. The retailer delivered better-than-expected earnings results for the second quarter of 2024 and hiked its earnings outlook for the full year. Here are a few noteworthy points on its Q2 performance:
Revenue and profit growth
Target’s revenue and earnings for the second quarter of 2024 increased on a year-over-year basis and surpassed analysts’ projections. Total revenue increased nearly 3% to $25.5 billion. Comparable sales rose 2% in the quarter. Both GAAP and adjusted EPS increased 42% to $2.57.
Improvement in discretionary trends
Target’s comparable store sales grew 0.7% and comparable digital sales rose 8.7% in Q2. The results benefited from a rise in traffic, which was partly offset by a drop in average ticket. Discretionary category trends continued to improve, particularly in apparel, where comp sales grew over 3% in the quarter. The beauty category continued its momentum with a 9% growth in comps.
Against an inflationary backdrop, consumers continue to be budget-conscious and they remain focused on value. In this environment, Target’s strategy of cutting prices on a wide range of frequently purchased items paid off, as it saw traffic growth in its food & beverage and essential categories during the quarter.
During the quarter, the company saw double-digit growth in its same-day delivery services, which was led by Drive Up and Target Circle 360. As mentioned on the conference call, same-day services now account for over two-thirds of sales. Of this, the biggest contribution comes from Drive Up, which generated sales of more than $2 billion in Q2.
Raised outlook
Target hiked its earnings outlook for the full year of 2024, based on strong profit performance in the first half. The company now expects GAAP and adjusted EPS to range between $9.00-9.70 versus the previous range of $8.60-$9.60. It expects comparable sales for the year to increase 0-2%.
For the third quarter of 2024, Target expects comparable sales to increase 0-2%. GAAP and adjusted EPS are expected to range between $2.10-2.40.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
